Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Indenbaum

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 27, 2021
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experienceYael Peled, Eilon Ram, Jacob Lavee, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2024
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024Efrat Bucris, Victoria Indenbaum, Tal Levin, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
The Science of the Total Environment|July 29, 2021
Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in IsraelItay Bar-Or, Merav Weil, Victoria Indenbaum, et al.
Biosensors|July 25, 2025
Sensitivity and Cross-Reactivity Analysis of Serotype-Specific Anti-NS1 Serological Assays for Dengue Virus Using Optical Modulation BiosensingSophie Terenteva, Linoy Golani-Zaidie, Shira Avivi, et al.
The Journal of Infectious Diseases|December 1, 2021
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World ExperienceMayan Gilboa, Michal Mandelboim, Victoria Indenbaum, et al.
Vaccine|May 31, 2022
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort studyShirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 2, 2025
Diagnostic insights from the 2024 West Nile Virus outbreak in Israel: Emphasizing the utility of molecular testing over serologyVictoria Indenbaum, Or Kriger, Zohar Mor, et al.
Viruses|January 21, 2023
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Michal Mandelboim, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 27, 2021
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experienceYael Peled, Eilon Ram, Jacob Lavee, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2024
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024Efrat Bucris, Victoria Indenbaum, Tal Levin, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
The Science of the Total Environment|July 29, 2021
Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in IsraelItay Bar-Or, Merav Weil, Victoria Indenbaum, et al.
Biosensors|July 25, 2025
Sensitivity and Cross-Reactivity Analysis of Serotype-Specific Anti-NS1 Serological Assays for Dengue Virus Using Optical Modulation BiosensingSophie Terenteva, Linoy Golani-Zaidie, Shira Avivi, et al.
The Journal of Infectious Diseases|December 1, 2021
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World ExperienceMayan Gilboa, Michal Mandelboim, Victoria Indenbaum, et al.
Vaccine|May 31, 2022
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort studyShirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 2, 2025
Diagnostic insights from the 2024 West Nile Virus outbreak in Israel: Emphasizing the utility of molecular testing over serologyVictoria Indenbaum, Or Kriger, Zohar Mor, et al.
Viruses|January 21, 2023
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Michal Mandelboim, et al.
Pageof 7